S Haubitz
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study
Gebreselassie H, Staehelin C, Furrer H, Schmid P, Bernasconi E, Cavassini M, de Lucia S, Fehr J, Stoeckle M, Veit O, Hatz C, Scherrer A, Haubitz S, Fux C, Kraus D. Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study. HIV Med 2017
01.03.2017Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study
01.03.2017HIV Med 2017
Gebreselassie H M, Staehelin C, Furrer H, Schmid Patrick, Bernasconi E, Cavassini M, de Lucia S, Fehr J, Stoeckle M, Veit O, Hatz C, Scherrer A, Haubitz S, Fux C A, Kraus D
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
Schaerer V, Rauch A, Fehr J, Metzner K, Furrer H, Günthard H, Böni J, Aouri M, Decosterd L, Schmid P, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study. Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Med 2015; 16:599-607.
02.07.2015Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
02.07.2015HIV Med 2015; 16:599-607
Schaerer V, Rauch A, Fehr J, Metzner K J, Furrer H, Günthard H F, Böni J, Aouri M, Decosterd L, Schmid Patrick, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study